Filing Details
- Accession Number:
- 0001127602-15-002265
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-20 18:28:33
- Reporting Period:
- 2015-01-15
- Filing Date:
- 2015-01-20
- Accepted Time:
- 2015-01-20 18:28:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236440 | E Floyd Bloom | Connaught House 1 Burlington Road Dublin 4 Ireland | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2015-01-15 | 3,000 | $67.24 | 107,281 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-01-15 | 500 | $68.08 | 106,781 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2015-01-16 | 16,500 | $67.07 | 90,281 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.00 to $67.695. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.00 to $67.355. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
